Here is what passes for useful information these days. For a fact or a belief to be useful, it has to be ALL CAPS, and you can never tell which is which. I have added my responses.
1. NNOX IS SITTING ON OVER $200 M IN CASH - THEY HAVE ENOUGH CASH TO LAST FOR MANY YEARS GIVEN THE CURRENT CASH BURN.
Yes, that translates to less than $5 a share (and falling every day), not even accounting for expenses that will come once the real lawsuits start coming.
2.FDA CLEARANCE HAS ALREADY BEEN GIVEN FOR THE SINGLE SOURCE. THE MULTISOURCE IS SIMPLY A BUNCH OF THESE! COULD SOMETHING GO WRONG - POSSIBLY BUT UNLIKELY AND IF IT DOES IM SURE THEY ARE WORKING CLOSELY WITH THE FDA TO RECITIFY [sic] TO ULTIMATELY GET APPROVAL.
The FDA cleared a Cart (a device that Nanox does not intend to market), not an Arc (the device that Nanox claims will be its first intended commercial device) - and there are reasons to believe the 510(k) Cart submission was fraudulent. The multi-source Arc is not just a bunch of Carts. Moreover, the Cart was cleared for "hands, wrists, and fingers" only, while the Arc's intended use is even more restricted - just one body part (per press release). Nanox is not seeking FDA approval - it is seeking FDA clearance (and it is illegal in the United States to claim FDA approval when there is only FDA clearance)
3.THE KOREA FACTORY HAS THE ABILTY TO PRODUCE SOME 50,000 MACHINES PER YEAR - THATS ALOT !!!! THE REALITY IS IT WILL PROBABLY NOT ALL GO TO MEDICAL USE.
There is no such Korean factory - the one that is being built will only supposedly make chips (and possibly tubes) enough for only 44,000 machines, or 24,000 machines, depending on the mood of the CEO, at full capacity (assuming 5 tubes per machine). These chips, of course, cannot be used to make any commercial (functional) x-ray tubes. The latest is that the machines are and will be produced (that is, assembled) in Israel - as of now, they are fake (have no x-ray tubes/detector, per "production" video).
Nanox has not licensed or sold or delivered any tube or machine since its predecessor announced the cold-cathode breakthrough in 2015. No FDA clearance or approval is needed for non-medical use.
4.YOU HAVE SOME BIG COMPANY NAMES INVESTED IN THIS TECHNOLOGY - SK TELECOM AND FUJI.
SK Telecom was introduced to Nanox by a convicted felon (based on his own testimony, now removed by Nanox), and issued a hilarious press release about curing cancer by causing cancer (the 1x1x1 initiative) with 5D (not to be confused with 5G). Fuji invested in Nanox predecessor company in exchange for licensing rights that expired in June 2020 (per Nanox letter to the SEC) with Fuji walking away - there is no record in Nanox SEC filings that Fuji is still an investor.
5.BACK TO THE FACT THESE TUBES WILL NOT ENTIRELY BE USED FOR MEDICAL EQUIPMENT - CHANCES ARE YOU WILL SEE THE BEING LISCENSED [sic] TO SECURITY INDUSTRY AND MANUFACTURING INDUSTRY - XRAY TECH IS USED IN AUTO AND CHIP MANUFACTURING TO SEE IF CRACKS EXIST OR CHIPS PRINTED CORRECTLY .
X-ray tech is used everywhere - true - and no specific regulatory approvals are needed in most cases (other than compliance with basic radiation safety regulations). Nanox has been unable to sell or license even one cathode, tube or device, despite claiming to have commercial cathodes and x-ray tubes for at least a year (and, again, having made its latest break-through in 2015).
6.THE FLOAT IS 50M SHARES OF WHICH 50% IS OWNED BY INSIDERS AND INSTITUTIONS. ONLY 25M SHARES EXIST FOR THE PEOPLE WHO WANT TO TRADE. THE REALITY IS SOME OF THOSE PEOPLE WILL BUY AND HOLD AND THUS FURTHER REDUCING THE REMAINING AVAILABLE SHARES.
Institutions and insiders do want to trade and do trade. The estimate for the 25 million "float" seems way off based on a brief perusal of the latest prospectus and the 144 forms. WSJ has the float at 34 million, and my estimate is way higher.
7.DOES ANYONE REALLY BELIEVE CONSTRUCTION OF A BUILDING IN KOREA WOULD OCCUR IF THEY DID NOT HAVE POSITIVE NEWS ON THE POTENTIAL OUTCOME OF THE FDA SUBMISSION? IM SO SICK OF SEEING MISINFORMATION BEING POSTED. LETS KEEP THIS FACTUAL LIST GOING PLEASE - I WILL UPDATE AS PEOPLE MAKE INTELLIGENT TRUE STATEMENTS. YES THE STOCK IS VOLATILE - BUT ITS JUST TIME BEFORE THOSE HANDS GET TAKEN OUT AND THEN YOU WILL HAVE A SIGNIFICANT BUNCH OF LEGACY INVESTORS WHICH WILL HOLD FOR SOME TIME TO COME. WHICH LEADS TO MY LAST FACT/BELIEF.
8. THIS COMPANY HAS TREMENDOUS OPPORTUNITY IN THE NEXT 2-5 YEARS. WHY> MEDICAL- LISCENSING [sic] AND ULTIMATELY THE POTENTIAL TO BE BOUGHT OUT BY A DIFFERENT COMPANY WITH A MORE ROBUST MANAGEMENT TEAM THAT WILL HAVE THE RESOURCES TO EXECUTE ALL OF THESE GREAT OPPORTUNITIES. THE CURRENT MANAGEMNET TEAM WILL DO A GREAT A JOB FOR NOW - BUT REALITY IS THIS THING WILL BE SOLD !!! AND I HOPE THEY REALIZE THE TRUE ENTERPRISE VALUE OF THIS COMPANY !!!!
Oh, the CEO is now being accused of not being robust. This did not end well.
Thank you, THOMAS @ Yahoo.
Update July 20, 2020: New USEFUL INFORMATION by Tumble @ Yahoo:
they spent a decade of R&D on their cold cathode technology, which they have patented... since competitors won't be able to beat them (their technology), they will have to join them. And NNOX has already said that it will let others use its technology and in return NNOX will receive recurring royalty payments... in other words, even without being used in NNOX machines, their technology will be a source of recurring revenue
And my response:
Nanox did not spend a decade of R&D on the "cold cathode technology," as Nanox is just three-year-old corporation (Nanox was incorporated on December 20, 2018 and commenced operations on September 3, 2019, per annual report). Nanox predecessor got the tech for free from Sony, which got it for free from Candescent prior to year 2000. Useless tech - never worked!
In November 1998, [Candescent] announced an agreement with Sony Corporation for joint development of a 14-inch diagonal FED by the year 2000. Both companies pledged to spend $50 million on this effort. Most of the work would be performed at CTC's plants. A team of six Sony engineers were sent to San Jose to begin the work, with some additional staff dedicated to the project in Japan.
The money was not spent. Candescent filed for bankruptcy in 2004. Sony abandoned the technology in 2006, with the final bell ringing in 2009 - after all these years, Sony obviously knew that the technology is useless, not just for displays/detectors, but also for x-ray generation (Sony has had some x-ray-related business over the years).
Update July 20, 2020 #2: About those cold cathodes - the only two successful commercial applications I am aware of are plasma displays (300V tube voltage) and CCFL backlight for notebooks (about 600V tube voltage) . Both peaked in early 21st century: 1) plasma displays were too hot, shiny, and cost could not decrease - commercial sales stopped in 2014-2016, 2) CCFL consumed too much power and had somewhat short life - replaced with LEDs around the same tine plasma display sales stopped. Of course, to make usable x-rays, the tube voltage is much higher, and cold cathodes simply can't cope (they short, melt, get dirty, and generally fail catastrophically). My estimate of cold-cathode x-ray tube sales worldwide is less than 500 units a year (almost all using CNT, none using Nanox "Spindt" pins), primarily for industrial application (some dental, and less than 100 units for limited diagnostics - mainly extremities). It is good to remember that prior to the introduction by GE of the hot cathode in 1913, all x-ray and fluorescent light tubes used cold cathodes. So Nanox is quite mistaken in its tech "essay" that you could find hot cathodes in the really-old fluorescent lights.
No comments:
Post a Comment